{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T03:32:52Z","timestamp":1782012772740,"version":"3.54.5"},"reference-count":169,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.pcad.2020.03.011","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T02:13:49Z","timestamp":1587435229000},"page":"271-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis"],"prefix":"10.1016","volume":"63","author":[{"given":"Jan-Peter","family":"Smedema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2020.03.011_bb0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Resp Crit Care Med"},{"issue":"7","key":"10.1016\/j.pcad.2020.03.011_bb0015","doi-asserted-by":"crossref","first-page":"e0179980","DOI":"10.1371\/journal.pone.0179980","article-title":"Immuno-histochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients","volume":"12","author":"Asakawa","year":"2017","journal-title":"PLos One"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Sem Resp Crit Care Med"},{"key":"10.1016\/j.pcad.2020.03.011_bb0025","first-page":"307","article-title":"Cases of Mortimer's malady, a form of lupus pernio","volume":"9","author":"Hutchinson","year":"1898","journal-title":"Arch Surg"},{"key":"10.1016\/j.pcad.2020.03.011_bb0030","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archinte.1929.00140050098009","article-title":"Boeck's sarcoid \u2013 report on a case with visceral involvement","volume":"44","author":"Bernstein","year":"1929","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.pcad.2020.03.011_bb0035","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"68(4)","key":"10.1016\/j.pcad.2020.03.011_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"26","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2020.03.011_bb0045","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2020.03.011_bb0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart: a clinico-pathological study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group II)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2020.03.011_bb0055","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinico-pathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.03.011_bb0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0065","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5858\/2009-0274-RA.1","article-title":"Cardiac sarcoidosis: a pathology-focused review","volume":"134","author":"Lagana","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.pcad.2020.03.011_bb0070","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2020.03.011_bb0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/RLU.0000000000001267","article-title":"Sarcoid pericarditis and large vessel vasculitis detected on FDG PET\/CT","volume":"41","author":"Patel","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.pcad.2020.03.011_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ehf2.12166","article-title":"Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance","volume":"4","author":"Smedema","year":"2017","journal-title":"ESC Heart Failure"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ehf2.12201","article-title":"Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis","author":"Smedema","year":"2018","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.pcad.2020.03.011_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijcard.2015.03.256","article-title":"Ventricular aneurysms in cardiac sarcoidosis: from pathophysiology to surgical treatment through a clinical case presenting with ventricular arrhythmias","volume":"186","author":"Pedrotti","year":"2015","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2020.03.011_bb0095","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/jmri.24196","article-title":"Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis","volume":"39","author":"Yang","year":"2014","journal-title":"J Magn Res Imag"},{"issue":"3","key":"10.1016\/j.pcad.2020.03.011_bb0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.14503\/THIJ-13-3208","article-title":"Cardiac sarcoidosis presenting as constrictive pericarditis","volume":"41","author":"Darda","year":"2014","journal-title":"Tex Inst Heart J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0105","first-page":"167","article-title":"Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinico-pathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0120","first-page":"1","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle- tracking strain analysis relates to outcomes in sarcoidosis","volume":"28","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.pcad.2020.03.011_bb0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.echo.2016.06.001","article-title":"Prevalence and correlates of early right ventricular dysfunction in sarcoidosis and its association with outcome","volume":"29","author":"Joyce","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2020.03.011_bb0130","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.amjcard.2017.02.010","article-title":"Incremental prognostic value of global longitudinal strain and 18-F Fludeoxyglucose Positon Emission Tomography in patients with systemic sarcoidosis","volume":"119","author":"Sperry","year":"2017","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2020.03.011_bb0135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/echo.13846","article-title":"Global longitudinal strain and long-term outcomes in asymptomaic extra-cardiac sarcoid patients with no apparent cardiovascular disease","volume":"35","author":"Felekos","year":"2018","journal-title":"Echocardiography"},{"issue":"10","key":"10.1016\/j.pcad.2020.03.011_bb0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1253\/jcj.64.755","article-title":"Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis","volume":"64","author":"Fuse","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2015.06.021","article-title":"Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis","volume":"116","author":"Kandolin","year":"2015","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2020.03.011_bb0150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1164\/rccm.201611-2183LE","article-title":"Exosomal MicroRNA for the detection of cardiac sarcoidosis","volume":"196","author":"Crouser","year":"2017","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.pcad.2020.03.011_bb0155","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jjcc.2018.06.004","article-title":"Serum microRNA-126 and -223 as a new generation biomarkers for sarcoidosis in patients with heart failure","volume":"72","author":"Fujiwara","year":"2018","journal-title":"J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0165","first-page":"1015.e1","article-title":"Isolated cardiac sarcoidosis: establising the diagnosis with electroanatomic mapping-guided endomyocardial biopsy","volume":"29","author":"Nery","year":"2013","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.pcad.2020.03.011_bb0170","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00392-007-0557-1","article-title":"Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis","volume":"96","author":"Borchert","year":"2007","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2020.03.011_bb0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacep.2017.09.175","article-title":"Characterization of the electroanatomic substrate in cardiac sarcoidosis: correlation with imaging findings of scar and inflammation","volume":"4","author":"Muser","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.pcad.2020.03.011_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004627","article-title":"Robotically assisted left ventricular biopsy to diagnose cardiac sarcoidosis: a multidisciplinary innovation leading to first-in-human case","volume":"11","author":"Bhimaraj","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2020.03.011_bb0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjcard.2014.11.028","article-title":"Outcomes in patients with high-degree atrioventri- cular block as the initial manifestation of cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjcard.2013.03.027","article-title":"Predictors of cardiac sarcoidosis using commonly available cardiac studies","volume":"112","author":"Freeman","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijcard.2017.07.027","article-title":"Novel ECG parameters are strongly associated with inflammatory 18F-FDG-PET findings in patients with suspected cardiac sarcoidosis","volume":"249","author":"Sipil\u00e4","year":"2017","journal-title":"Intern J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0200","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1378\/chest.128.4.2619","article-title":"QT dispersion in cardiac sarcoidosis","volume":"128","author":"Uyarel","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pcad.2020.03.011_bb0205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00380-016-0881-3","article-title":"T wave amplitude in lead aVR as a novel diagnostic marker of cardiac sarcoidosis","volume":"32","author":"Tanaka","year":"2017","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10840-015-9978-3","article-title":"Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator","volume":"43","author":"Kron","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"issue":"6","key":"10.1016\/j.pcad.2020.03.011_bb0215","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter- defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2020.03.011_bb0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1542-474X.2010.00411.x","article-title":"Diagnostic utility of signal-averaged ECG for detection of cardiac sarcoidosis","volume":"16","author":"Schuller","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jce.12302","article-title":"Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator","volume":"25","author":"Mohsen","year":"2014","journal-title":"J Cardiovasc Electrophys"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.128.1.30","article-title":"Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical Centres in the Netherlands","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjcard.2005.03.059","article-title":"Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis","volume":"96","author":"Aizer","year":"2005","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2020.03.011_bb0245","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10554-016-1024-8","article-title":"Assessment of myocardial delayed enhancement with cardiac computed tomography in cardiomyopathies: a prospective comparison with delayed enhancement cardiac magnetic resonance imaging","volume":"33","author":"Lee","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2005.07.059","article-title":"Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography","volume":"112","author":"Smedema","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0255","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1378\/chest.126.4.1372","article-title":"Usefulness of dual 67 gallium\/ Tc99 Sestamibi SPECT scanning in the diagnosis of cardiac sarcoidosis","volume":"126","author":"Nakazawa","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2020.03.011_bb0260","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.pcad.2020.03.011_bb0265","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and meta-analysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.pcad.2020.03.011_bb0275","first-page":"10s0","article-title":"Identification of cardiac sarcoidosis with 13N-NH3\/18F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med"},{"issue":"47","key":"10.1016\/j.pcad.2020.03.011_bb0280","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"issue":"35","key":"10.1016\/j.pcad.2020.03.011_bb0285","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/eurheartj\/ehv278","article-title":"Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography\/computed tomography","volume":"36","author":"Reiter","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0290","doi-asserted-by":"crossref","unstructured":"Pizarro C, Kluenker F, Dabir D, Thomas D, Gaertner FC, Essler M, Groh\u00e9 C, Nickenig G, Skowasch D. Cardiovascular magnetic resonance imaging and clinical performance of somato- statin positron emission tomography in cardiac sarcoidosis. ESC Heart Failure 218;5(2): 249\u2013261. doi:https:\/\/doi.org\/10.1002\/ehf2.12243.","DOI":"10.1002\/ehf2.12243"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0295","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with Fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0300","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0305","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2020.03.011_bb0310","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance amongst patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.pcad.2020.03.011_bb0315","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0320","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccm.2008.03.014","article-title":"The immunology of sarcoidosis","volume":"29","author":"Gerke","year":"2008","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immunity in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0330","first-page":"376","article-title":"Resident macrophages: near and dear to your heart","volume":"169","author":"Munshi","year":"2017","journal-title":"Editorial Cell"},{"key":"10.1016\/j.pcad.2020.03.011_bb0335","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"Hamzeh","year":"2015","journal-title":"Nature Rev Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0340","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-012-9358-3","article-title":"Ideopathic giant cell myocarditis and cardiac sarcoidosis","volume":"1896","author":"Blauwet","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pcad.2020.03.011_bb0345","series-title":"Cardiovascular Effects of Systemic Diseases and Conditions","article-title":"Cardiovascular pathology","author":"Silber","year":"2001"},{"key":"10.1016\/j.pcad.2020.03.011_bb0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1532-429X-15-91","article-title":"Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update","volume":"15","author":"Kramer","year":"2013","journal-title":"J Cardiovasc Magn Res"},{"key":"10.1016\/j.pcad.2020.03.011_bb0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","article-title":"Standard image interpretation and post processing in cardiovascular magnetic resonance: society for cardiovascular magnetic resonance (SCMR) board of trustees task force on standard post processing","volume":"15","author":"Schulz-Menger","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2020.03.011_bb0360","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00004728-200209000-00017","article-title":"Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced and cine magnetic resonance imaging: initial results of a prospective study","volume":"26","author":"Vignaux","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.pcad.2020.03.011_bb0365","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9343(01)00677-5","article-title":"Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging","volume":"110","author":"Shimada","year":"2001","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.pcad.2020.03.011_bb0370","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1161\/01.CIR.0000158436.18971.A1","article-title":"Images in cardiovascular medicine. Follow-up of cardiac sarcoidosis by magnetic resonance imaging","volume":"111","author":"Stauder","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.03.011_bb0375","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/eurheartj\/ehi258","article-title":"Delayed enhancement cardiovascular magnetic resonance assessment of non-ischemic cardiomyopathies","volume":"26","author":"Mahrhold","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0380","first-page":"647041","article-title":"Case report: cardiac Sarcoidosis or Giant cell myocarditis? On treatment improvement of fulminanant myocarditis as demonstrated by cardiovascular magnetic resonance imaging","volume":"2012","author":"Bogabathina","year":"2012","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0385","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004417","article-title":"Comprehensive cardiovascular magnetic resonance assessment in patients with sarcoidosis and preserved left ventricular ejection fraction","volume":"9","author":"Greulich","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0390","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Resp Crit Care Med"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0395","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2017162732","article-title":"T1 and T2 mapping in recognition of early cardiac involvement in sarcoidosis","volume":"285","author":"Puntmann","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.pcad.2020.03.011_bb0400","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2020.03.011_bb0405","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/a-0598-5099","article-title":"Diagnostic value of cardiac magnetic strain analysis for detection of cardiac sarcoidosis","volume":"190","author":"Dabir","year":"2018","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"10.1016\/j.pcad.2020.03.011_bb0410","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2214\/ajr.151.5.915","article-title":"MR imaging of myocardial sarcoidosis","volume":"151","author":"Riedy","year":"1988","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0415","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/hrt.2004.058016","article-title":"Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance","volume":"92","author":"Schulz-Menger","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2020.03.011_bb0420","series-title":"MR Contrast Agents for Cardiac Imaging","first-page":"32","article-title":"Clinical Cardiac MRI","author":"Ni","year":"2012"},{"issue":"3","key":"10.1016\/j.pcad.2020.03.011_bb0425","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/rg.2017160082","article-title":"Radiologic-pathologic correlation of primary and secondary cardiomyopathies: MR imaging and histopathological findings in hearts from autopsy and transplantation","volume":"37","author":"Hashimura","year":"2017","journal-title":"Radiographics"},{"key":"10.1016\/j.pcad.2020.03.011_bb0430","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/jmri.24264","article-title":"Gadopentetate diglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging","volume":"39","author":"Rudolph","year":"2014","journal-title":"J Magn Res Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0435","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2214\/AJR.09.2520","article-title":"Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456 930 doses","volume":"193","author":"Hunt","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0440","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jcmg.2011.06.019","article-title":"Acute adverse reaction to gadolinium-based contrast agents in CMR: multi-Centre experience in 17 767 patients from the euro CMR registry","volume":"4","author":"Bruder","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0445","unstructured":"FDA drug safety communication: New Warnings for Using Gadolinium-Based Contrast Agents in Patients with Kidney Dysfunction. 12\/10 Update. fda.gov."},{"issue":"3","key":"10.1016\/j.pcad.2020.03.011_bb0450","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/JCMR-120022267","article-title":"How we perform delayed enhancement imaging","volume":"5","author":"Kim","year":"2003","journal-title":"J Cardiovasc Magn Res"},{"key":"10.1016\/j.pcad.2020.03.011_bb0455","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1378\/chest.128.3.1629","article-title":"The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2020.03.011_bb0460","first-page":"150","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0465","first-page":"381","article-title":"Automated scar quantification by CMR: a step in the right direction","volume":"5","author":"White","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.pcad.2020.03.011_bb0470","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijcard.2016.07.233","article-title":"High mass (>18 g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy proven extra-cardiac sarcoidosis","volume":"222","author":"Agoston-Coldea","year":"2016","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2020.03.011_bb0475","article-title":"Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations","volume":"11","author":"Hundley","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6","key":"10.1016\/j.pcad.2020.03.011_bb0480","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophys"},{"key":"10.1016\/j.pcad.2020.03.011_bb0485","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcmg.2015.11.002","article-title":"T1mapping by CMR imaging: from histological validation to clinical implication","volume":"9","author":"Kammerlander","year":"2016","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2020.03.011_bb0490","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovascular Magn Res"},{"key":"10.1016\/j.pcad.2020.03.011_bb0495","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2015.10.199","article-title":"Correspondence. Native T1 in deciphering the reversible myocardial inflammation in cardiac sarcoidosis with anti-inflammatory treatment","volume":"203","author":"Isted","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0500","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcmg.2015.11.008","article-title":"Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling","volume":"9","author":"Treibel","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0505","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10334-017-0631-2","article-title":"Towards accurate and precise T1 and extracellular volume mapping in the myocardium: a guide to current pitfalls and their solutions","volume":"31","author":"Cameron","year":"2018","journal-title":"MAGMA"},{"issue":"9","key":"10.1016\/j.pcad.2020.03.011_bb0510","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10554-017-1127-x","article-title":"Magnetic resonance imaging for characterizing myocardial diseases","volume":"33","author":"Saeed","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.pcad.2020.03.011_bb0515","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ejrad.2013.06.005","article-title":"T2-weighted imaging of the heart \u2013 a pictoral review","volume":"82","author":"Mirakhur","year":"2013","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.pcad.2020.03.011_bb0520","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jim-2016-000144","article-title":"Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis","volume":"64","author":"Crouser","year":"2016","journal-title":"J Invest Med"},{"key":"10.1016\/j.pcad.2020.03.011_bb0525","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005592","article-title":"Seeing beyond the obvious. Subclinical cardiac sarcoidosis revealed by cardiovascular magnetic resonance mapping","volume":"9","author":"Ferreira","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.pcad.2020.03.011_bb0530","doi-asserted-by":"crossref","first-page":"e004333","DOI":"10.1161\/CIRCEP.116.004333","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electr"},{"key":"10.1016\/j.pcad.2020.03.011_bb0535","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systemic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2020.03.011_bb0540","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2020.03.011_bb0545","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ehjci\/jey090","article-title":"Hydrid positron emission tomography \u2013 magnetic resonance of the heart: current state of the art and future applications","volume":"19","author":"Nazir","year":"2018","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.pcad.2020.03.011_bb0550","first-page":"3191","article-title":"Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: were are we now?","volume":"1","author":"Bietenbeck","year":"2016","journal-title":"Int J Nano Med"},{"key":"10.1016\/j.pcad.2020.03.011_bb0555","first-page":"1","article-title":"Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction","volume":"0","author":"Stirrat","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2020.03.011_bb0560","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCIMAGING.112.000125","article-title":"Selective in vivo visualization of immune-cell infiltration in a mouse model of auto-immune myocarditis by fluorine-19 cardiac magnetic resonance","volume":"6","author":"Van Heeswijk","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.pcad.2020.03.011_bb0565","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"10.1016\/j.pcad.2020.03.011_bb0570","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.hrthm.2017.03.039","article-title":"Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices","volume":"14","author":"Strom","year":"2017","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.pcad.2020.03.011_bb0575","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1007\/s00330-018-5396-0","article-title":"Cardiac implanted electronic devices and MRI safety in 2018-the state of play","volume":"28","author":"Shulman","year":"2018","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0580","first-page":"105","article-title":"Value of magnetic resonance imaging in cardiac sarcoidosis. Apropos of a case","volume":"87","author":"Dupuis","year":"1994","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.pcad.2020.03.011_bb0585","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.110.2.562","article-title":"Diagnosis of cardiac sarcoidosis aided by MRI","volume":"110","author":"Chandra","year":"1996","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.pcad.2020.03.011_bb0590","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1253\/jcj.64.679","article-title":"Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis","volume":"64","author":"Matsumori","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0595","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Japanese Ministery Health Welfare","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord (Jpn)"},{"key":"10.1016\/j.pcad.2020.03.011_bb0600","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0033-1359197","article-title":"Diagnostik and Therapie der kardialen Sarkoidose","volume":"68","author":"Costabel","year":"2014","journal-title":"Pneumatologie"},{"key":"10.1016\/j.pcad.2020.03.011_bb0605","first-page":"19","article-title":"The WASOG Sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasculitis and Diffuse Lung Diseases"},{"key":"10.1016\/j.pcad.2020.03.011_bb0610","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0615","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RTI.0b013e3182761830","article-title":"Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function","volume":"28","author":"Watanabe","year":"2013","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0620","article-title":"Review article. Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis","author":"Bravo","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2020.03.011_bb0625","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s12350-016-0658-1","article-title":"Isolated cardiac sarcoidosis. A focused review of an under-recognized entity","volume":"25","author":"Okada","year":"2018","journal-title":"J Nuclear Cardiology"},{"key":"10.1016\/j.pcad.2020.03.011_bb0630","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis. Epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.03.011_bb0635","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2015.08.025","article-title":"F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis","volume":"116","author":"Simonen","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0640","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1253\/circj.71.1937","article-title":"Cardiac sarcoidosis underlies idiopathic dilated cardiomyopathy \u2013 importance of mediastinal lymphadenopathy in differential diagnosis","volume":"71","author":"Otsuka","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0645","first-page":"89","volume":"27","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord (Jpn)"},{"issue":"6","key":"10.1016\/j.pcad.2020.03.011_bb0650","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/eurheartj\/ehx689","article-title":"Isolated cardiac sarcoidosis: the crucial role of multimodal imaging with positron emission tomography\/magnetic resonance imaging in diagnosis and therapy surveillance","volume":"39","author":"Steger","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0655","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2017.09.204","article-title":"How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body 18F-fluorodeoxyglucose positron emission tomography","volume":"253","author":"Juneau","year":"2018","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0660","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12350-018-1425-2","article-title":"Importance of extracardiac FDG uptake to diagnose cardiac sarcoidosis","volume":"27","author":"Tahara","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0665","series-title":"Guideline for the Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases from the Japanese Ministery of Health and Welfare","first-page":"23","author":"Hiraga","year":"1993"},{"key":"10.1016\/j.pcad.2020.03.011_bb0670","first-page":"1073","volume":"18","year":"2017","journal-title":"Eur Heart J CVImaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0675","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for 18F-fluodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.pcad.2020.03.011_bb0680","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.11-3214","article-title":"Supraventricular arrhythmias in patients with cardiac sarcoidosis","volume":"143","author":"Viles-Gonzalez","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.pcad.2020.03.011_bb0685","doi-asserted-by":"crossref","first-page":"omy016","DOI":"10.1093\/omcr\/omy016","article-title":"Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis","volume":"2018","author":"Spence","year":"2018","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.pcad.2020.03.011_bb0690","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehr490","article-title":"Imaging the right heart: the use of integrated multimodality imaging","volume":"33","author":"Valsangiocomo Buechel","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0695","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehl336","article-title":"Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance","volume":"27","author":"Maceira","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2020.03.011_bb0700","doi-asserted-by":"crossref","first-page":"e003738","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis in myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction. Risk stratification using cardiac magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.pcad.2020.03.011_bb0705","first-page":"634","article-title":"Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death","volume":"16","author":"Nadel","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0710","doi-asserted-by":"crossref","first-page":"e003040","DOI":"10.1161\/JAHA.115.003040","article-title":"Magnetic resonance imaging as a predictor of survival free of life-threatening arrhythmias and transplantation in cardiac sarcoidosis","volume":"5","author":"Ekstr\u00f6m","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.pcad.2020.03.011_bb0715","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.113.002518","article-title":"The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy","volume":"128","author":"Gulati","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2020.03.011_bb0720","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCEP.113.000932","article-title":"Arrhythmogenic right ventricular dysplasia\/ cardiomyopathy and cardiac Sarcoidosis. Distinguishing features when the diagnosis is unclear","volume":"7","author":"Philips","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0725","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijcard.2014.01.006","article-title":"Myocardial stress perfusion-fibrosis imaging pattern in sarcoidosis, assessed by cardiovascular magnetic resonance imaging","volume":"172","author":"Mavrogeni","year":"2014","journal-title":"Int J Cardiol"},{"issue":"20","key":"10.1016\/j.pcad.2020.03.011_bb0730","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2016.09.023","article-title":"Myocardial blood flow and inflammatory cardiac sarcoidosis","volume":"10","author":"Kruse","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0735","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9343(88)80340-1","article-title":"Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis","volume":"85","author":"Tellier","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2020.03.011_bb0740","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","article-title":"Role of cardiac magnetic resonance imaging in the diagnosis and prognosis of nonischemic cardiomyopathy","volume":"10","author":"Patel","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0745","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RTI.0b013e3182761830","article-title":"Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function","volume":"28","author":"Watanabe","year":"2013","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0750","unstructured":"Smedema JP, van Geuns RJ, Truter R, Mayosi BM, Crijns HJGM. Contrast-enhanced cardiac magnetic resonance: distinction between cardiac sarcoidosis and infarction scar. Sarc Vasc Diff Lung Dis 2017;34:307\u2013314. http:\/\/www.mattioli1885journals.com\/index.php\/ sarcoidosis\/article\/view\/5715."},{"key":"10.1016\/j.pcad.2020.03.011_bb0755","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Bruder","year":"2013","journal-title":"J Am Coll Cardiol Img"},{"issue":"7","key":"10.1016\/j.pcad.2020.03.011_bb0760","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simutaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2020.03.011_bb0765","doi-asserted-by":"crossref","first-page":"e006145","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophys"},{"key":"10.1016\/j.pcad.2020.03.011_bb0770","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2020.03.011_bb0775","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000437","article-title":"Risk stratification for major adverse cardiac events and ventricular tachyarrhythmia's by cardiac MRI in patients with sarcoidosis","volume":"3","author":"Yasuda","year":"2016","journal-title":"Open Heart"},{"issue":"4","key":"10.1016\/j.pcad.2020.03.011_bb0780","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.14-0139","article-title":"Incidence and prognostic significance of myocardial late gadolinium-enhancement in sarcoidosis patients without cardiac manifestation","volume":"146","author":"Nagai","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2020.03.011_bb0785","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jjcc.2012.08.002","article-title":"Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis","volume":"60","author":"Shafee","year":"2012","journal-title":"J Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2020.03.011_bb0790","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC CVImaging"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0795","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jce.13119","article-title":"Outcome of patients with cardiac sarcoidosis who received cardiac synchronization therapy: comparison with dilated cardiomyopathy patients","volume":"28","author":"Yufu","year":"2017","journal-title":"J Cardiovasc Electrophys"},{"key":"10.1016\/j.pcad.2020.03.011_bb0800","first-page":"1","article-title":"Effect of cardiac resynchronization therapy on left ventricular remodeling in patients with cardiac sarcoidosis","volume":"00","author":"Patel","year":"2018","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0805","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacep.2016.09.012","article-title":"Cardiac electrophysiology procedures, know unkowns, and unknown unknowns: the potential of magnetic resonance guidance","volume":"3","author":"Nazarian","year":"2017","journal-title":"JACC Clin Electrophys"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0810","doi-asserted-by":"crossref","first-page":"e005973","DOI":"10.1161\/CIRCEP.117.005973","article-title":"Standard ablation versus magnetic imaging-guided ablation in the treatment of ventricular tachycardia","volume":"11","author":"Zghaib","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0815","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12350-012-9668-9","article-title":"The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis","volume":"20","author":"Mc Ardle","year":"2013","journal-title":"J Nuclear Cardiol"},{"key":"10.1016\/j.pcad.2020.03.011_bb0820","first-page":"e350","volume":"117","author":"Epstein","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0825","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2020.03.011_bb0830","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1749-6632.1986.tb18531.x","article-title":"The prognosis of sarcoid heart disease in the United Kingdom","volume":"465","author":"Fleming","year":"1986","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.pcad.2020.03.011_bb0835","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12968-017-0357-3","article-title":"Targeted endomyocardial biopsy guided by real-time cardiovascular magnetic resonance","volume":"19","author":"Unterberg-Buchwald","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.pcad.2020.03.011_bb0840","doi-asserted-by":"crossref","first-page":"85","DOI":"10.15420\/aer.2017:1:2","article-title":"Cardiac electrophysiology under MRI guidance: an emerging technology","volume":"6","author":"Chubb","year":"2017","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"11","key":"10.1016\/j.pcad.2020.03.011_bb0845","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/europace\/euy040","article-title":"Magnetic resonance imaging guidance for the optimization of ventricular tachycardia ablation","volume":"20","author":"Mukherjee","year":"2018","journal-title":"Europace"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:19:08Z","timestamp":1758500348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062020300657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":169,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0033062020300657"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2020.03.011","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2020.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}